Revisiting the intrinsic mycobiome in pancreatic cancer.
Revisiting the intrinsic mycobiome in pancreatic cancer.
复制标题
重新审视胰腺癌的内在真菌组。
DOI:
10.1038/s41586-023-06292-1
复制
发表时间:
2023
期刊:
影响因子:
64.8
通讯作者:
Allen,PeterJ
中科院分区:
文献类型:
--
作者:
Fletcher,AshleyA;Kelly,MatthewS;Eckhoff,AustinM;Allen,PeterJ
A growing body of literature suggests that alterations in the human microbiome are causative of disease initiation and progression. Aykut et al. 1 have provided evidence that alterations in the gut fungal microbiome (the ‘mycobiome’), along with the presence of fungal elements within pancreatic tissue (specifically those of the genus Malassezia), are associated with pancreatic oncogenesis. On analysing the human sequencing data presented in the original article, we found few fungal reads in pancreatic tissue samples and did not identify differences in pancreatic or gut mycobiome composition between healthy participants and patients with pancreatic ductal adenocarcinoma (PDAC). Our reanalysis of these data does not support an association between an intrinsic pancreatic mycobiome and the development of human PDAC, and illustrates the challenges in analysing microbiome sequencing data from low-biomass samples.Using sequence analysis of the internal transcribed spacer (ITS) region of fungi, Aykut et al. characterized the mycobiome of 5 healthy human pancreatic tissue samples, 13 PDAC tissue samples and 18 faecal samples from patients with PDAC. They also sequenced nine faecal samples from healthy participants, although these data were not presented in the paper. Focusing only on the analysis of these human samples, we retrieved the raw sequencing data that were publicly available through the National Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA) to confirm the findings from the paper and to compare the gut and pancreatic mycobiomes of the healthy participants and patients with PDAC.